Back to feed
Lead dossierLanded14:37
Summary
Concenter BioPharma Developing Novel, First in Class Drugs, Treating and Preventing Type 2 Diabetes, Based on a Core-Technology-Platform.
- Audience
- General
- Category
- SaaS
- Country
- Unknown
- Status
- Live